Gallium novel antibiotic

Did you know? 
Gallium acts as an iron mimic, disrupting bacterial iron metabolism by substituting for iron, thereby interfering with essential bacterial processes when ingested by bacteria. It is unique among metals because it melts in your hand.

Gallium

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

Fact-checked by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

November 22, 2024

Gallium is studied for its unique antimicrobial and anticancer properties. It inhibits metalloproteinases, disrupts bacterial iron metabolism, and may enhance antibiotic efficacy, particularly against resistant strains. Gallium compounds show potential as non-traditional therapeutic agents in treating infections and inhibiting cancer cell invasion and metastasis.

research-feed Research feed

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

Fact-checked by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More

Last Updated: 2024-04-21

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Overview

Gallium is a unique and versatile metal that presents a wide array of clinical and therapeutic potential due to its distinctive physical and chemical properties. With a melting point of about 29.76°C (85.57°F), it can melt in one’s hand, and it freezes again at slightly lower temperatures, which makes it a subject of interest for both scientific study and practical applications. Gallium has been studied for its unique antimicrobial and anticancer properties. It inhibits metalloproteinases, disrupts bacterial iron metabolism, and may enhance antibiotic efficacy, particularly against resistant strains. Gallium compounds show potential as non-traditional therapeutic agents in treating infections and inhibiting cancer cell invasion and metastasis.

Applications of Gallium

Inhibition of Metalloproteinases: Gallium is notably effective in inhibiting matrix metalloproteinases (MMPs), a group of enzymes critical in the degradation of the extracellular matrix. This action is pivotal for controlling pathological states where MMPs lead to excessive tissue breakdown, such as in cancer metastasis, chronic wounds, endometriosis, and inflammatory diseases like rheumatoid arthritis. By interfering with MMP activity, it can help manage the progression of these diseases and mitigate the associated tissue damage.

Anti-Inflammatory Properties: Gallium also exhibits anti-inflammatory properties, potentially through the modulation of MMP activity. This dual role in both MMP inhibition and inflammation reduction highlights its therapeutic potential in treating conditions where inflammation plays a key role, such as in autoimmune diseases and persistent infections.

Antimicrobial Activity: One of the most compelling aspects of gallium’s role in medicine is its antimicrobial activity. Gallium acts as an iron mimic, interfering with iron metabolism in bacteria and fungi. Since many pathogens require iron for vital processes, gallium disrupts these processes when taken up in place of iron, leading to the inhibition of bacterial growth and survival. This property makes gallium-based compounds promising candidates as next-generation antibiotics, particularly for fighting antibiotic-resistant bacteria [1].

Future Directions

Current research into gallium-based therapies focuses on enhancing its bioavailability and efficacy. Studies are aimed at examining various formulations that can be administered effectively with minimal side effects. The research extends to evaluating the synergistic effects when combined with other therapeutic agents to enhance its antimicrobial and anti-inflammatory actions without compromising safety.

Implications

The development of gallium-based treatments represents a promising advancement in addressing hard-to-treat infections and conditions associated with high matrix degradation and inflammation levels. As research progresses, these compounds might offer new avenues for treating currently challenging conditions, such as metastatic cancers and chronic inflammatory diseases.

Research Feed

Gallium Antimicrobial Agents: Innovations in Combating Drug-Resistant Pathogens
February 4, 2022
/
Metals
Metals

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin ut laoreet tortor. Donec euismod fermentum pharetra. Nullam at tristique enim. In sit amet molestie

Alias iure reprehenderit aut accusantium. Molestiae dolore suscipit. Necessitatibus eum quaerat. Repudiandae suscipit quo necessitatibus. Voluptatibus ullam nulla temporibus nobis. Atque eaque sed totam est assumenda. Porro modi soluta consequuntur veritatis excepturi minus delectus reprehenderit est. Eveniet labore ut quas minima aliquid quibusdam. Vitae possimus fuga praesentium eveniet debitis exercitationem deleniti.

Create a free account to unlock this study summary.

Microbiome Insiders can read two study summaries for any topic on Microbiome.

(Get started with your free account)

Relaxed fibronectin: a potential novel target for imaging endometriotic lesions
February 10, 2024
/
Metals
Metals

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin ut laoreet tortor. Donec euismod fermentum pharetra. Nullam at tristique enim. In sit amet molestie

Alias iure reprehenderit aut accusantium. Molestiae dolore suscipit. Necessitatibus eum quaerat. Repudiandae suscipit quo necessitatibus. Voluptatibus ullam nulla temporibus nobis. Atque eaque sed totam est assumenda. Porro modi soluta consequuntur veritatis excepturi minus delectus reprehenderit est. Eveniet labore ut quas minima aliquid quibusdam. Vitae possimus fuga praesentium eveniet debitis exercitationem deleniti.

Create a free account to unlock this study summary.

Microbiome Insiders can read two study summaries for any topic on Microbiome.

(Get started with your free account)

GS2 Gallium Complex: A Novel Inhibitor of MMP-14 for Anti-Metastatic Cancer Therapy
August 16, 2017
/
Metals
Metals

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin ut laoreet tortor. Donec euismod fermentum pharetra. Nullam at tristique enim. In sit amet molestie

Alias iure reprehenderit aut accusantium. Molestiae dolore suscipit. Necessitatibus eum quaerat. Repudiandae suscipit quo necessitatibus. Voluptatibus ullam nulla temporibus nobis. Atque eaque sed totam est assumenda. Porro modi soluta consequuntur veritatis excepturi minus delectus reprehenderit est. Eveniet labore ut quas minima aliquid quibusdam. Vitae possimus fuga praesentium eveniet debitis exercitationem deleniti.

Create a free account to unlock this study summary.

Microbiome Insiders can read two study summaries for any topic on Microbiome.

(Get started with your free account)

Matrix Metalloproteinases (MMPs)

Matrix Metalloproteinases (MMPs) are zinc-dependent enzymes that regulate extracellular matrix remodeling, with critical roles in health, disease, and interactions with the microbiome.

Endometriosis

Endometriosis involves ectopic endometrial tissue causing pain and infertility. Validated and Promising Interventions include Hyperbaric Oxygen Therapy (HBOT), Low Nickel Diet, and Metronidazole therapy.

References

  1. Advancement of Gallium and Gallium-Based Compounds as Antimicrobial Agents.. Li F, Liu F, Huang K, Yang S.. (Front Bioeng Biotechnol. Feb 4, 2022)

Li F, Liu F, Huang K, Yang S.

Advancement of Gallium and Gallium-Based Compounds as Antimicrobial Agents.

Front Bioeng Biotechnol. Feb 4, 2022

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.